COOPERVISION (UK) HOLDINGS LIMITED

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Standalone (parent only)

Auditor

KPMG LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“The financial statements have been prepared on a going concern basis, which the directors consider to be appropriate for the following reasons. The company is a holding entity with no trading operations and a minimal level of expected expenditure over the next 12 months. It is not reliant on external funding or dividend income from subsidiaries to meet its obligations. While the company may receive dividend income during this period, the directors do not consider this income necessary to support the company's ability to continue as a going concern. Accordingly, and having considered all relevant information available at the date of approval of these financial statements, the directors are satisfied that the company will have sufficient resources to meet its liabilities as they fall due for at least 12 months from the date of approval. Therefore, the financial statements have been prepared on a going concern basis.”

Group structure

1. COOPERVISION (UK) HOLDINGS LIMITED · parent
   1. CooperVision Manufacturing Ltd 1% · UK · Distribution & Manufacturing
   2. CooperVision Lens Care Ltd 1% · UK · Holding company
   3. CooperVision Ltd 1% · UK · Distribution
   4. No. 7 Contact Lens Laboratory Ltd 1% · UK · Manufacture & Sale of contact Lenses
   5. CooperVision Australia Pty Ltd 1% · Australia · Distribution & Manufacturing
   6. CooperVision Distribution SRL 1% · Belgium · Distribution
   7. CooperVision Canada Corp. 1% · Canada · Distribution
   8. CooperVision Chile SpA 1% · Chile · Distribution
   9. CooperVision SAS 1% · France · Distribution
   10. CooperVision GmbH 1% · Germany · Distribution
   11. CooperVision Italia Srl 1% · Italy · Distribution
   12. CooperVision Korea Ltd. 1% · South Korea · Distribution
   13. Viendo Por Su Salud, S.A. de C.V. 1% · Mexico · Distribution
   14. CooperVision Nederland BV 1% · Netherlands · Distribution
   15. CooperVision Japan Inc. 1% · Japan · Distribution
   16. CooperVision Iberia SL 1% · Spain · Distribution
   17. Vision Hydron Produtos Opticos LDA 1% · Portugal · Distribution
   18. CooperVision S.A. Pty Limited 1% · South Africa · Distribution
   19. CooperVision Nordic AB 1% · Sweden · Distribution
   20. CooperVision Sarl 1% · Switzerland · Distribution
   21. CooperVision (Taiwan) Co Ltd 1% · Taiwan · Distribution
   22. CooperVision Turkey Kontakt Lens Ticaret Limited 1% · Turkey · Distribution
   23. CooperVision LLC 1% · Russia · Distribution
   24. Aspect Vision Holdings Ltd 1% · UK · Non trading
   25. CooperVision Poland sp z.o.o. 1% · Poland · Distribution
   26. Sauflon CL Ltd 1% · UK · Distribution
   27. CooperVision CL Kft 1% · Hungary · Distribution
   28. Blanchard Vision Corp 1% · Canada · Distribution
   29. Enseyes ApS 1% · Denmark · Distribution
   30. CooperVision Speciality Eyecare Hong Kong Ltd 1% · China · Distribution
   31. CooperVision Israel Ltd 1% · Israel · Distribution & Manufacturing
   32. Procornea Nederland B.V. 1% · Netherlands · Distribution & Manufacturing
   33. CooperVision RUS LLC 1% · Russia · Distribution
   34. Sauflon International Ltd 1% · UK · Non trading
   35. CooperVision Czech S.r.o. 1% · Czech Republic · Distribution
   36. Evitas Ltd 0% · Israel · Dissolved

Significant events

• “On 26 February 2025 the Company issued and allotted 1 S1 Ordinary Share to its immediate parent company CooperVision Global Limited for $12,600k, accordingly the Company has increased Share Capital by $1 and increased Share Premium by the remaining $12,600k.”
• “On 26 February 2025 the Company increased its investment in CooperVision Lens Care Limited via a cash contribution of £30,400k in consideration of a further 1 £1 Ordinary Share at a premium of £30,400k.”
• “Sauflon International Limited was liquidated on 14 November 2023.”
• “Evitas Ltd was dissolved on 25 September 2024.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

4

last 12 months

Capital events

1

last 24 months

Officers appointed

0

last 12 months

Officers resigned

0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

• Turnover

  —

  Not reported

• Cash

  +817.9%

  £91,179 → £836,916

• Net assets

  0%

  £805,890,289 → £805,961,453

• Employees

  —

  Not reported

• Operating profit

  +96.4%

  -£122,313 → -£4,448

• Profit before tax

  -75.6%

  £7,979,985 → £1,947,368

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers